Amicus Therapeutics, Inc. (LON:0HF9)
London · Delayed Price · Currency is GBP · Price in USD 14.32
0.00 (-0.01%)
Feb 12, 2026, 4:50 PM GMT
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 3.29 billion as of February 12, 2026. Its market cap has increased by 41.85% in one year.
Market Cap
3.29B
Enterprise Value
3.42B
Revenue
445.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.32
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 3.29B, an increase of 1,931.02%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.29B | 0.61% |
| Dec 31, 2025 | 3.27B | 45.56% |
| Dec 31, 2024 | 2.25B | -31.18% |
| Dec 29, 2023 | 3.27B | 14.75% |
| Dec 30, 2022 | 2.85B | 19.78% |
| Dec 31, 2021 | 2.38B | -46.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |